Sfoglia per Autore
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
2011 Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Quirini F; Baccarani M.
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.
2011 Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti E.; Derenzini E.; Pileri S.; Baccarani M.
The prognostic value of biologic markers in classical hodgkin lymphoma (CHL) patients.
2011 Agostinelli C.; Gallamini A.; Rigacci L.; Vitolo U.; Stracqualursi L.; Piccaluga P.; Stelitano C.; Patti C.; Argnani. L.; Broccoli A.; Levis A.; D’Amore F.; Zinzani P.; Pileri S.A.
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
2011 Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Metodologia della Ricerca Clinica ed Epidemiologica. Guida pratica per il reumatologo.
2012 Salaffi F, Scirè C, Monti C, Argnani L.
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
2012 Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L; Argnani L; Casadei B; Pulsoni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A.
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients.
2012 Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S.
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients.
2012 Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G.
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
2013 Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M.
Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma.
2013 Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL.
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.
2013 Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gianni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L
Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin.
2013 Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;Zinzani PL
Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain
2013 Battisti E.; Albanese A.; Guerra L.; Argnani L.; Giordano N.
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.
2013 Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL
Primary ocular adnexal lymphomas: a retrospective study of 25 patients.
2013 Gandolfi L;Stefani G;Narducci R;Argnani L;Polito E;Zinzani PL
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
2013 Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L
Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.
2013 Zinzani PL;Pellegrini C;Derenzini E;Argnani L;Pileri S
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
2013 Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. | Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Qui...rini F; Baccarani M. | 2011-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. | Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti ...E.; Derenzini E.; Pileri S.; Baccarani M. | 2011-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| The prognostic value of biologic markers in classical hodgkin lymphoma (CHL) patients. | Agostinelli C.; Gallamini A.; Rigacci L.; Vitolo U.; Stracqualursi L.; Piccaluga P.; Stelitano C....; Patti C.; Argnani. L.; Broccoli A.; Levis A.; D’Amore F.; Zinzani P.; Pileri S.A. | 2011-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. | Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argn...ani L.; Pileri S.; Baccarani M. | 2011-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Metodologia della Ricerca Clinica ed Epidemiologica. Guida pratica per il reumatologo. | Salaffi F, Scirè C, Monti C, Argnani L. | 2012-01-01 | - | Mattioli 1885 Editore | 3.01 Monografia / trattato scientifico in forma di libro | - |
| Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). |
Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L; Argnani L; Casadei B; Pul...soni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A. |
2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. | Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni... L.; Argnani L.; Baccarani M.; Fanti S. | 2012-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. | Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati... M; Bandini G. | 2012-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. | Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta ...MR; Narducci R; Argnani L; Zinzani PL. | 2013-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. | Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gia...nni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L | 2013-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | haematol.2012.083048.full.pdf |
| Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. | Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;...Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain | Battisti E.; Albanese A.; Guerra L.; Argnani L.; Giordano N. | 2013-01-01 | EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE | - | 1.01 Articolo in rivista | - |
| Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. | Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL | 2013-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Primary ocular adnexal lymphomas: a retrospective study of 25 patients. | Gandolfi L;Stefani G;Narducci R;Argnani L;Polito E;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. | Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L | 2013-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients. | Zinzani PL;Pellegrini C;Derenzini E;Argnani L;Pileri S | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. | Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; P...ileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile